Point: Care of potential low-risk basal cell carcinomas (BCCs) at the end of life : The key role of the dermatologist - 17/06/15
Doi : 10.1016/j.jaad.2015.02.005
Eleni Linos, MD, DrPH a, ⁎ 
, Timothy Berger, MD a, b, Mary-Margaret Chren, MD a, b
, Timothy Berger, MD a, b, Mary-Margaret Chren, MD a, b a Department of Dermatology, University of California, San Francisco, San Francisco, California
b Dermatology Service, San Francisco Veterans Affairs Medical Center, San Francisco, California
∗Reprint requests: Eleni Linos, MD, DrPH, Department of Dermatology, University of California, San Francisco, 2340 Sutter St, Room N421, Mail Code: Box 0808, San Francisco, CA 94143-0808.
Key words : basal cell carcinoma, elders, end of life, skin cancer, squamous cell carcinoma
Le texte complet de cet article est disponible en PDF.
Plan
| This research was funded by the National Center for Advancing Translational Sciences, National Institutes of Health, through University of California San Francisco, Clinical and Translational Science Institute (UCSF-CTSI) grant number KL2TR000143; National Institute of Arthritis and Musculoskeletal and Skin Diseases K24; 5K24AR052667-09, the Dermatology Foundation Career Development Award; and the UCSF Claude D. Pepper Older Americans Independence Center P30AG044281. |
|
| Disclosure: Dr Mary-Margaret Chren serves as a consultant to Genentech Inc. Drs Linos and Berger have no conflicts of interest to declare. |
© 2015
American Academy of Dermatology, Inc. Tous droits réservés.
Vol 73 - N° 1
P. 158-161 - juillet 2015 Retour au numéro
Article précédent
- Should self-destructive behavior affect a patient's access to scarce medical resources?
- Catherine S. Yang, George Kroumpouzos, Lionel Bercovitch
- Counterpoint: Limited life expectancy, basal cell carcinoma, health care today, and unintended consequences
- Scott W. Fosko
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?